Merck has reached an agreement that will let other drug makers produce its COVID-19 pill, though many countries are excluded from the pact.
Merck and the United Nations-backed Medicines Patent Pool announced the agreement, saying it would help broaden access to the treatment in 105 low- and middle-income countries.
